1. Home
  2. DHX vs IMUX Comparison

DHX vs IMUX Comparison

Compare DHX & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DHI Group Inc.

DHX

DHI Group Inc.

HOLD

Current Price

$4.60

Market Cap

212.3M

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$7.40

Market Cap

155.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHX
IMUX
Founded
1991
2016
Country
United States
United States
Employees
N/A
66
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.3M
155.8M
IPO Year
2007
2013

Fundamental Metrics

Financial Performance
Metric
DHX
IMUX
Price
$4.60
$7.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
12
Target Price
$6.75
★ $43.09
AVG Volume (30 Days)
172.3K
★ 382.7K
Earning Date
11-09-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.00
EPS
★ 0.10
N/A
Revenue
★ $127,826,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.24
N/A
P/E Ratio
$47.50
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.44
$0.51
52 Week High
$5.19
$17.43

Technical Indicators

Market Signals
Indicator
DHX
IMUX
Relative Strength Index (RSI) 44.72 36.21
Support Level $4.54 $6.35
Resistance Level $4.89 $8.60
Average True Range (ATR) 0.21 0.65
MACD -0.04 0.19
Stochastic Oscillator 14.90 46.67

Price Performance

Historical Comparison
DHX
IMUX

About DHX DHI Group Inc.

DHI Group Inc is a provider of software products, online tools, and services that deliver career marketplaces to candidates and employers in the United States. The company operates through two reportable segments: ClearanceJobs and Dice. Its brands enable recruiters and hiring managers to search, match, and connect with skilled technologists, particularly in technology and active government security clearance, while professionals find job opportunities, job advice, and personalized data. ClearanceJobs connects security-cleared professionals with employers in a secure environment and supports engagement through messaging and live video. Dice, which generates maximum revenue, is a destination for technology and engineering talent, offering job postings across a range of technology roles.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

Share on Social Networks: